RVPH REVIVA PHARMACEUTICALS HOLDINGS, INC.
Pharmaceutical Preparations · OTC · SEC CIK 1742927 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY—
TTM net income YoY50.3%
TTM EPS YoY—
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—
Returns
ROE-128.3%
ROA-68.8%
ROIC (approx.)—
Asset turnover—
Leverage & solvency
Liabilities / assets29.5%
Debt / equity0.00x
Current ratio3.39x
Interest coverage-2,310.59x
Cash quality & payout
Operating cash flow / net income1.23x
Accruals ratio15.7%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | — | — |
| R&D expense | $11.71M | $22.91M |
| SG&A expense | $8.49M | $7.89M |
| Operating income | -$20.20M | -$30.80M |
| Interest expense | $13,402 | $18,497 |
| Pretax income | -$19.85M | -$29.90M |
| Income tax | $18,889 | $19,514 |
| Net income | -$19.86M | -$29.92M |
| EPS (basic) | -5.48 | -17.73 |
| EPS (diluted) | — | — |
| Balance sheet | ||
| Cash & equivalents | $14.44M | $13.48M |
| Current assets | $15.10M | $14.68M |
| Total assets | $15.92M | $15.50M |
| Current liabilities | $7.28M | $14.60M |
| Short-term debt | $406,875 | $458,154 |
| Total liabilities | $7.28M | $14.69M |
| Shareholders' equity | $8.65M | $812,572 |
| Shares outstanding | 5.87M | 2.36M |
| Cash flow statement | ||
| Operating cash flow | -$24.59M | -$33.54M |
| Financing cash flow | $25.56M | $23.65M |
| Stock-based compensation | $2.23M | $1.63M |
Free plan shows the latest 2 periods; Pro shows all 10 🔒
· This company does not report gross profit in XBRL.
· This company reports EPS only by share class (e.g. class A/B), so it is shown as —.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.